Bevacizumab is equally effective and no more toxic in elderly patients with advanced colorectal cancer: a subgroup analysis from the AGITG MAX trial: an international randomised controlled trial of Capecitabine, Bevacizumab and Mitomycin C

✍ Scribed by Price, T. J.; Zannino, D.; Wilson, K.; Simes, R. J.; Cassidy, J.; Van Hazel, G. A.; Robinson, B. A.; Broad, A.; Ganju, V.; Ackland, S. P.; Tebbutt, N. C.

• Book ID: 125420181
• Publisher: Oxford University Press
• Year: 2012
• Tongue: English
• Weight: 238 KB
• Volume: 23
• Category: Article
• ISSN: 0923-7534
• DOI: 10.1093/annonc/mdr488